Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient with Newly Diagnosed Breast Cancer

Pınar Pelin Özcan; Zehra Pınar Koç; Gökçe Yavan; Adil Gümüş

Görüntü Sunumu

Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient with Newly Diagnosed Breast Cancer

Yıl 2022, Cilt: 2 Sayı: 1, 17 - 19, 15.04.2022

Pınar Pelin Özcan Zehra Pınar Koç Gökçe Yavan Adil Gümüş

Öz

Imaging plays an important role in the evaluation of cancer patients for management of most appropriate treatment options. FDG PET-CT imaging in various cancer patients has been widely used for staging, restaging, and therapy response for various cancer patients. We hereby, report incidentally detected COVID-19 disease FDG PET-CT findings of a newly diagnosed breast cancer patient and follow-up imaging findings.

Anahtar Kelimeler

FDG, PET-CT, COVID-19

Kaynakça

1. Huang HL, Allie R, Gnanasegaran G, Bomanji J. COVID19-Nuclear Medicine Departments, be prepared! Nucl Med Commun 2020;41:297-299
2. Treglia, G. The role of 18F-FDG PET for COVID-19 infection: Myth versus reality. Clin. Transl. Imaging 2020
3. Albano, D.; Bertagna, F.; Bertoli, M.; et al. Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients UndergoingNuclear Medicine Procedures in a High-Prevalence Region. J. Nucl. Med. 2020, 61, 632–636
4. Bahloul, A.; Boursier, C.; Jeulin, H.; et.al. CT abnormalitiesevocative of lung infection are associated with lower 18F-FDG uptake in confirmed COVID-19 patients.Eur. J. Nucl. Med. Mol. Imaging 2020
5. Cabrera Villegas, A.; Romero Robles, L.G.; Boulvard Chollet, X.L.E.; et.al. [18F]-FDG PET/CT in oncologic patients with unsuspected asymptomatic infection with SARS-CoV-2. Eur. J.Nucl. Med. Mol. Imaging 2020
6. Charters, P.F.P.; Little, D.; Rodrigues, J.C.L.; et.al. 18FDG-PET/CT findings inCOVID-19: A single centre retrospective radiological review. BJR Case Rep. 2020, 6, 20200091
7. Dietz, M.; Chironi, G.; Claessens, et al. COVID-19 pneumonia: Relationship between inflammation assessed bywhole-body FDG PET/CT and short-term clinical outcome. Eur. J. Nucl. Med. Mol. Imaging 2020
8. Boulvard Chollet, X.L.E.; Romero Robles, L.G.; Garrastachu, P.; et.al. 18F-FDG PET/CT in Hodgkin LymphomaWith Unsuspected COVID-19. Clin. Nucl. Med. 2020, 45, 652–653
9. Kamani, C.H.; Jreige, M.; Pappon, M.; et.al. Added value of 18F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever.Eur. J. Nucl. Med. Mol. Imaging 2020, 47, 2036–2037
10. Halsey, R.; Priftakis, D.; Mackenzie, S.;et.al. COVID-19 in the act: Incidental 18F-FDG PET/CT findings in asymptomaticpatients and those with symptoms not primarily correlated with COVID-19 during the United Kingdomcoronavirus lockdown. Eur. J. Nucl. Med. Mol. Imaging 2020
11. Salvatore Annunziata, Roberto C. Delgado Bolton , Christel-Hermann Kamani , et.al. Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19:A Systematic Review.Pharmaceuticals 2020, 13, 377

Yıl 2022, Cilt: 2 Sayı: 1, 17 - 19, 15.04.2022

Pınar Pelin Özcan Zehra Pınar Koç Gökçe Yavan Adil Gümüş

Öz

Kaynakça

1. Huang HL, Allie R, Gnanasegaran G, Bomanji J. COVID19-Nuclear Medicine Departments, be prepared! Nucl Med Commun 2020;41:297-299
2. Treglia, G. The role of 18F-FDG PET for COVID-19 infection: Myth versus reality. Clin. Transl. Imaging 2020
3. Albano, D.; Bertagna, F.; Bertoli, M.; et al. Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients UndergoingNuclear Medicine Procedures in a High-Prevalence Region. J. Nucl. Med. 2020, 61, 632–636
4. Bahloul, A.; Boursier, C.; Jeulin, H.; et.al. CT abnormalitiesevocative of lung infection are associated with lower 18F-FDG uptake in confirmed COVID-19 patients.Eur. J. Nucl. Med. Mol. Imaging 2020
5. Cabrera Villegas, A.; Romero Robles, L.G.; Boulvard Chollet, X.L.E.; et.al. [18F]-FDG PET/CT in oncologic patients with unsuspected asymptomatic infection with SARS-CoV-2. Eur. J.Nucl. Med. Mol. Imaging 2020
6. Charters, P.F.P.; Little, D.; Rodrigues, J.C.L.; et.al. 18FDG-PET/CT findings inCOVID-19: A single centre retrospective radiological review. BJR Case Rep. 2020, 6, 20200091
7. Dietz, M.; Chironi, G.; Claessens, et al. COVID-19 pneumonia: Relationship between inflammation assessed bywhole-body FDG PET/CT and short-term clinical outcome. Eur. J. Nucl. Med. Mol. Imaging 2020
8. Boulvard Chollet, X.L.E.; Romero Robles, L.G.; Garrastachu, P.; et.al. 18F-FDG PET/CT in Hodgkin LymphomaWith Unsuspected COVID-19. Clin. Nucl. Med. 2020, 45, 652–653
9. Kamani, C.H.; Jreige, M.; Pappon, M.; et.al. Added value of 18F-FDG PET/CT in a SARS-CoV-2-infected complex case with persistent fever.Eur. J. Nucl. Med. Mol. Imaging 2020, 47, 2036–2037
10. Halsey, R.; Priftakis, D.; Mackenzie, S.;et.al. COVID-19 in the act: Incidental 18F-FDG PET/CT findings in asymptomaticpatients and those with symptoms not primarily correlated with COVID-19 during the United Kingdomcoronavirus lockdown. Eur. J. Nucl. Med. Mol. Imaging 2020
11. Salvatore Annunziata, Roberto C. Delgado Bolton , Christel-Hermann Kamani , et.al. Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19:A Systematic Review.Pharmaceuticals 2020, 13, 377

Toplam 11 adet kaynakça vardır.

Ayrıntılar

Birincil Dil	İngilizce
Konular	Onkoloji ve Karsinogenez
Bölüm	Case Reports
Yazarlar	Pınar Pelin Özcan Bu kişi benim 0000-0003-0147-2678 Zehra Pınar Koç Bu kişi benim 0000-0002-3274-5790 Gökçe Yavan Bu kişi benim 0000-0002-7332-6293 Adil Gümüş Bu kişi benim 0000-0003-3428-7778
Yayımlanma Tarihi	15 Nisan 2022
Yayımlandığı Sayı	Yıl 2022 Cilt: 2 Sayı: 1

Kaynak Göster

APA	Özcan, P. P., Koç, Z. P., Yavan, G., Gümüş, A. (2022). Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient with Newly Diagnosed Breast Cancer. Molecular Oncologic Imaging, 2(1), 17-19.
AMA	Özcan PP, Koç ZP, Yavan G, Gümüş A. Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient with Newly Diagnosed Breast Cancer. Molecular Oncologic Imaging. Nisan 2022;2(1):17-19.
Chicago	Özcan, Pınar Pelin, Zehra Pınar Koç, Gökçe Yavan, ve Adil Gümüş. “Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient With Newly Diagnosed Breast Cancer”. Molecular Oncologic Imaging 2, sy. 1 (Nisan 2022): 17-19.
EndNote	Özcan PP, Koç ZP, Yavan G, Gümüş A (01 Nisan 2022) Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient with Newly Diagnosed Breast Cancer. Molecular Oncologic Imaging 2 1 17–19.
IEEE	P. P. Özcan, Z. P. Koç, G. Yavan, ve A. Gümüş, “Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient with Newly Diagnosed Breast Cancer”, Molecular Oncologic Imaging, c. 2, sy. 1, ss. 17–19, 2022.
ISNAD	Özcan, Pınar Pelin vd. “Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient With Newly Diagnosed Breast Cancer”. Molecular Oncologic Imaging 2/1 (Nisan 2022), 17-19.
JAMA	Özcan PP, Koç ZP, Yavan G, Gümüş A. Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient with Newly Diagnosed Breast Cancer. Molecular Oncologic Imaging. 2022;2:17–19.
MLA	Özcan, Pınar Pelin vd. “Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient With Newly Diagnosed Breast Cancer”. Molecular Oncologic Imaging, c. 2, sy. 1, 2022, ss. 17-19.
Vancouver	Özcan PP, Koç ZP, Yavan G, Gümüş A. Incidentally Detected COVID-19 Case and FDG-PET-CT Findings in a Patient with Newly Diagnosed Breast Cancer. Molecular Oncologic Imaging. 2022;2(1):17-9.